These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

723 related items for PubMed ID: 12767980

  • 1. Genome replication, virion secretion, and e antigen expression of naturally occurring hepatitis B virus core promoter mutants.
    Parekh S, Zoulim F, Ahn SH, Tsai A, Li J, Kawai S, Khan N, Trépo C, Wands J, Tong S.
    J Virol; 2003 Jun; 77(12):6601-12. PubMed ID: 12767980
    [Abstract] [Full Text] [Related]

  • 2. Effect of basal core promoter and pre-core mutations on hepatitis B virus replication.
    Jammeh S, Tavner F, Watson R, Thomas HC, Karayiannis P.
    J Gen Virol; 2008 Apr; 89(Pt 4):901-909. PubMed ID: 18343830
    [Abstract] [Full Text] [Related]

  • 3. In vitro resistance to interferon-alpha of hepatitis B virus with basic core promoter double mutation.
    Wang Y, Wei L, Jiang D, Cong X, Fei R, Chen H, Xiao J, Wang Y.
    Antiviral Res; 2007 Aug; 75(2):139-45. PubMed ID: 17397939
    [Abstract] [Full Text] [Related]

  • 4. Persistence of Hepatitis B Virus DNA and the Tempos between Virion Secretion and Genome Maturation in a Mouse Model.
    Wu SY, Chang YS, Chu TH, Shih C.
    J Virol; 2019 Nov 15; 93(22):. PubMed ID: 31462567
    [Abstract] [Full Text] [Related]

  • 5. Mechanism of HBV genome variability and replication of HBV mutants.
    Tong S.
    J Clin Virol; 2005 Dec 15; 34 Suppl 1():S134-8. PubMed ID: 16461214
    [Abstract] [Full Text] [Related]

  • 6. Basal core promoter and precore mutations in the hepatitis B virus genome enhance replication efficacy of Lamivudine-resistant mutants.
    Tacke F, Gehrke C, Luedde T, Heim A, Manns MP, Trautwein C.
    J Virol; 2004 Aug 15; 78(16):8524-35. PubMed ID: 15280461
    [Abstract] [Full Text] [Related]

  • 7. Role of core protein mutations in the development of occult HBV infection.
    Chen J, Liu B, Tang X, Zheng X, Lu J, Zhang L, Wang W, Candotti D, Fu Y, Allain JP, Li C, Li L, Li T.
    J Hepatol; 2021 Jun 15; 74(6):1303-1314. PubMed ID: 33453326
    [Abstract] [Full Text] [Related]

  • 8. Occult hepatitis B virus infection with positive hepatitis B e antigen.
    Han Z, Liu Y, Pan J, Bi Y, Liu J, Zhou YH.
    Clin Chim Acta; 2015 Jan 01; 438():266-8. PubMed ID: 25218700
    [Abstract] [Full Text] [Related]

  • 9. Hepatitis B virus harboring nucleotide deletions in the core promoter region and genotype B correlate with low viral replication activity in anti-HBe positive carriers.
    Li KS, Yamashiro T, Sumie A, Terao H, Mifune K, Nishizono A.
    J Clin Virol; 2001 Dec 01; 23(1-2):97-106. PubMed ID: 11595588
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hepatitis B virus core promoter mutations in children with multiple anti-HBe/HBeAg reactivations result in enhanced promoter activity.
    Gerner P, Lausch E, Friedt M, Tratzmüller R, Spangenberg C, Wirth S.
    J Med Virol; 1999 Dec 01; 59(4):415-23. PubMed ID: 10534721
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The G1613A mutation in the HBV genome affects HBeAg expression and viral replication through altered core promoter activity.
    Li MS, Lau TC, Chan SK, Wong CH, Ng PK, Sung JJ, Chan HL, Tsui SK.
    PLoS One; 2011 Dec 01; 6(7):e21856. PubMed ID: 21814558
    [Abstract] [Full Text] [Related]

  • 15. Mutations of pre-core and basal core promoter before and after hepatitis B e antigen seroconversion.
    Kamijo N, Matsumoto A, Umemura T, Shibata S, Ichikawa Y, Kimura T, Komatsu M, Tanaka E.
    World J Gastroenterol; 2015 Jan 14; 21(2):541-8. PubMed ID: 25593470
    [Abstract] [Full Text] [Related]

  • 16. Hepatitis B virus genotype C isolates with wild-type core promoter sequence replicate less efficiently than genotype B isolates but possess higher virion secretion capacity.
    Qin Y, Tang X, Garcia T, Hussain M, Zhang J, Lok A, Wands J, Li J, Tong S.
    J Virol; 2011 Oct 14; 85(19):10167-77. PubMed ID: 21775451
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.